EXACT Therapeutics AS (OSL:EXTX)
Norway flag Norway · Delayed Price · Currency is NOK
0.6750
+0.0250 (3.85%)
At close: Oct 2, 2026

EXACT Therapeutics AS Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4387238385360522
Market Cap Growth
-68.16%-63.30%-38.21%6.94%-31.02%-40.97%
Enterprise Value
-629223347283396
Last Close Price
0.681.383.7612.0012.0017.40

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
547.471479.72-86354.11791.9810035.84
PB Ratio
0.652.842.068.545.534.93
P/TBV Ratio
0.652.842.068.545.534.93

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-494.09-77902.05621.977610.71

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.010.030.030.02
Net Debt / Equity Ratio
-0.74-0.78-0.86-1.00-1.04-0.96
Net Debt / EBITDA Ratio
0.660.291.940.971.721.77
Net Debt / FCF Ratio
0.730.331.210.961.991.80
Asset Turnover
0.000.00-00.010
Quick Ratio
3.090.852.833.564.8110.57
Current Ratio
4.161.653.543.614.8110.57
Return on Equity (ROE)
-113.45%-118.93%-65.17%-87.74%-46.95%-44.15%
Return on Assets (ROA)
-51.64%-48.10%-30.80%-42.05%-25.47%-25.67%
Return on Capital Employed (ROCE)
-116.70%-276.40%-45.70%-105.60%-61.40%-55.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-177.49%-99.61%-22.00%-12.55%-11.14%-11.23%
FCF Yield
-157.04%-82.83%-34.49%-12.31%-9.47%-10.87%
Buyback Yield / Dilution
-74.89%-82.42%-8.10%-6.94%-0.06%-0.04%